Attending Digital Pharma Innovation Week? Don’t miss PRECISIONxtract’s Marty Samples and Jon Bambalas’ presentation “Get Creative: How to Modernize Your Brand’s Pull Through Approach” June 15 at 1:35 PM EDT. Also stop by our virtual booth to connect with one of our experts.
Congratulations to Richard Macaulay on his well-attended presentation “The New SMC-Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?” at Virtual ISPOR 2021. Did you miss Richard’s presentation?
PRECISIONadvisor’s Director David Carr recently attended World Orphan Drug Conference 2021, and found two panels particularly insightful: “Outlook on European market access strategies for rare diseases” and “Pricing & reimbursement for rare diseases in the United States.” In case you couldn’t attend, David noted the key takeaways of each presentation.
(more…)
Did you miss PRECISIONadvisor’s Richard Macaulay present “The Future of Reimbursement for Cell & Gene Therapies” at World EPA Congress 2021?
(more…)
Directly following the cell therapy panel discussion in part 1, Precision experts Deb Phippard and David Parker, and Project Pharma’s Tony Khoury joined C-Suite leaders from advanced therapy companies for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 2- Gene Therapy.
Miss ASGCT 2021? Check out this cell therapy panel discussion you won’t want to miss! Precision experts David Parker, Alex Grosvenor and Megan Liles, and Project Farma’s John Khoury join biotech executives on the front lines of development for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 1 – Cell Therapy.
Attending Virtual ISPOR 2021 May 17-20? PRECISIONadvisors and PRECISIONheor will be attending with 22 posters, panels, and workshops! Stay tuned for valuable insights from our experts that you won’t want to miss.
The shift from fee-for-service to value-based care has been undeniably gaining momentum over the past few years. However, 2020 brought an incredible influx of factors that were not previously accounted for… To keep a finger on the pulse, Precision developed and fielded a new proprietary survey to see how the healthcare landscape, as well as health systems and payers, are adapting to the new challenges and opportunities posed as a result. Today, we’re here to share those survey results with you.
Attending AMCP 2021? Check out two PRECISIONvalue poster presentations, as well as our virtual booth which will be featuring our new white paper “Engaging With Integrated Delivery Networks to Address the Social Determinants of Health”. While you’re there, don’t forget to schedule some time to speak with some of our experts!
Congratulations to PRECISIONadvisor’s Richard Macaulay on presenting “The Future of Innovative Reimbursement for Cell and Gene Therapies” at World EPA Congress 2021.
(more…)
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
